Background: Despite seventeen decades of continuous clinical use, the neuronal mechanisms through which volatile anesthetics act to produce unconsciousness remain obscure. One emerging possibility is that anesthetics exert their hypnotic effects by hijacking endogenous arousal circuits. A key sleep-promoting component of this circuitry is the ventrolateral preoptic nucleus (VLPO), a hypothalamic region containing both state-independent neurons and neurons that preferentially fire during natural sleep. Results: Using c-Fos immunohistochemistry as a biomarker for antecedent neuronal activity, we show that isoflurane and halothane increase the number of active neurons in the VLPO, but only when mice are sedated or unconscious. Destroying VLPO neurons produces an acute resistance to isoflurane-induced hypnosis. Electrophysiological studies prove that the neurons depolarized by isoflurane belong to the subpopulation of VLPO neurons responsible for promoting natural sleep, whereas neighboring non-sleep-active VLPO neurons are unaffected by isoflurane. Finally, we show that this anesthetic-induced depolarization is not solely due to a presynaptic inhibition of wake-active neurons as previously hypothesized but rather is due to a direct postsynaptic effect on VLPO neurons themselves arising from the closing of a background potassium conductance. Conclusions: Cumulatively, this work demonstrates that anesthetics are capable of directly activating endogenous sleep-promoting networks and that such actions contribute to their hypnotic properties.
Introduction
General anesthetics have been used to manipulate consciousness in patients for nearly 170 years, but it is still not known how these drugs impart hypnosis. At the molecular level, the number of possible effector sites is staggering: dozens of molecules are known to be sensitive to anesthetic agents, including many types of ion channels (reviewed in [1, 2] ), gap-junction channels [3] , and G protein-coupled receptors [4] . Furthermore, it is clear that there is no single molecular site of action shared by all anesthetic agents [1] . Thus, the actions of general anesthetics must be understood in the context of neural anatomy and network connectivity.
Though anesthetic-induced hypnosis and natural sleep are distinct states, they share many similarities (reviewed in [5, 6] ), leading to the increasingly popular theory that anesthetics may induce hypnosis by acting on endogenous arousal neural circuitry [7] . Much of the recent research has focused on anesthetics inhibiting wake-active nuclei such as the tuberomammillary nucleus [7, 8] , but it remains unclear to what extent sleep-promoting nuclei, such as the ventrolateral preoptic nucleus (VLPO), are involved in generating the hypnotic state.
The VLPO is a predominately sleep-active nucleus containing GABAergic and galaninergic neurons that project to many arousal-promoting nuclei throughout the neuroaxis [9] . Several general anesthetics, including chloral hydrate, propofol, various barbiturates, dexmedetomidine, and isoflurane, have been shown to increase the number of active VLPO neurons [7, 10, 11 ]. Yet, ablation of VLPO neurons, which would be predicted to produce resistance to anesthesia, is known to cause an accrual of sleep debt [12] and has recently been reported to cause increased sensitivity to isoflurane anesthesia [13] . Thus, it remains unclear whether VLPO activation contributes to anesthetic-induced hypnosis or whether it is a secondary effect unrelated to behavioral state [14] .
In the present study, we demonstrate that isoflurane dosedependently increases the number of active VLPO neurons, but not at a subsedative dose or when the animals' behavioral state is reversed via pressure reversal. By using whole-cell recordings in hypothalamic slices, we identify isofluraneactivated neurons as belonging specifically to the putative sleep-promoting subpopulation of VLPO neurons. We demonstrate that isoflurane acts directly on these neurons to reduce a basal potassium conductance and thereby increase inward (depolarizing) current. Finally, targeted lesioning of the VLPO produces an acute resistance to induction by isoflurane. These results are consistent with anesthetic agents acting on the endogenous arousal neural circuitry to produce hypnosis and suggest that the VLPO plays a critical role in anesthetic induction.
Results

Hypnotic Doses of Isoflurane or Halothane Increase Expression of c-Fos in a Subset of VLPO Neurons
To determine whether VLPO neurons are active during volatileanesthetic-induced hypnosis, we exposed mice to oxygen with or without volatile anesthetics for 2 hr, either during the period of maximal activity following lights-out (''dark phase'') or during the period of maximal sleep following lights-on (''light phase''). Following sacrifice, we analyzed immunohistochemical expression of c-Fos, a marker of antecedent neuronal activity. Consistent with previous reports [15, 16] , and in contrast to most brain regions [5, 6, 17, 18] , the VLPO of nonanesthetized mice sacrificed during the light phase had a 2.5-fold increase in the number of c-Fos-positive nuclei compared to mice sacrificed during the dark phase (p < 0.001; Figure 1 ). Similar increases were also observed for *Correspondence: kelzma@uphs.upenn.edu sedative and hypnotic levels of isoflurane: 2 hr exposure to 0.6% isoflurane produced an increase of 215% 6 79% (p < 0.001) in c-Fos-positive counts, and 1.2% isoflurane produced an increase of 179% 6 28% (p < 0.01). To determine the generalizability among inhaled volatile agents, we tested an equipotent dose of halothane at 1% [19] . Halothane similarly increased the number of c-Fos-reactive neurons in VLPO (150% 6 33%, p < 0.01). There were no significant differences in c-Fos counts between 0.6% isoflurane, 1.2% isoflurane, and 1.0% halothane (p > 0.05). Conversely, a subsedative dose of 0.3% isoflurane had no effect (76% 6 50%, p > 0.05). To determine whether natural sleep and anesthesia have an additive effect on the number of c-Fos-positive cells in VLPO, we exposed mice in their light phase to 1.2% isoflurane, and we found no difference in c-Fos expression compared to a 1.2% isoflurane dark-phase exposure (decrease of 12% 6 7%, p > 0.05).
To explore the behavioral relevance of VLPO activation during hypnosis, we used pressure reversal to separate anesthetic exposure from hypnosis. Although there are no known chemical antagonists capable of reversing surgical planes of anesthesia [20] , it has been well known for over half a century that exposing organisms to high external pressures can reverse the actions of many anesthetics [21] [22] [23] . Specifically, 70 atmospheres (atm) is known to decrease isoflurane potency by more than 50% in mice [22] . After being anesthetized with 1.0% isoflurane at 1 atm for 30 min, the mice were pressurized to 70 atm with helium gas and remained at pressure for 2 hr, during which time the mice regained their righting reflex, as observed through a viewport. Pressure reversal resulted in an 85% 6 2% reduction in c-Fos-positive neurons in VLPO compared to mice anesthetized with 1.2% isoflurane at 1 atm (p < 0.001). Consistent with the behavioral reversal of anesthesia, pressure reversal fully reverted levels of c-Fos expression back to those of wakefulness ( Figure 1 ) with no differences among the isoflurane-exposed 70 atm pressure-reversed group, the 1 atm awake oxygen control group, and the 70 atm pressure-awakened oxygen control group (p > 0.05).
Electrophysiological Classification of VLPO Neurons
Forty-nine VLPO neurons were recorded from acutely prepared preoptic hypothalamic slices obtained from 40 anesthetic-naive mice. Neurons were classified according to their response to a bath application of 100 mM norepinephrine (NA): 15 neurons were strongly depolarized by NA (5.41 6 0.97 mV, p < 0.01) and were classified as NA(+), whereas 34 were hyperpolarized (23.61 6 0.80 mV, p < 0.01) and were classified as NA(2) (Figure 2 ). In keeping with previous literature [24] , the majority (79%) of NA(2) neurons had clearly discernible low-threshold spikes (LTSs) following hyperpolarization ( Figure 2B , insert), whereas few NA(+) cells (13%) exhibited an LTS. The NA(2) LTS VLPO neurons are believed to be the putative sleep-promoting subset, whereas their neighboring NA(+) neurons that lack LTS are state indifferent. Morphological analysis of biocytin-filled neurons revealed that all NA(+) cells were bipolar, whereas NA(2) cells tended to be multipolar, as reported previously [24] [25] [26] . Basic membrane properties such as membrane resistance and actionpotential characteristics did not differ between these two neuronal subtypes (Table 1) .
Isoflurane Directly Depolarizes NA(2) VLPO Neurons by Decreasing Potassium Conductance Two concentrations of isoflurane dissolved in artificial cerebrospinal fluid (aCSF) were used: 240 mM (roughly equivalent to 1.2% in oxygen) and 480 mM (roughly equivalent to 2.4% in oxygen). Neither dose had a significant effect on NA(+) neurons, though there was a consistent trend toward a reduction in firing rate (20.46 6 0.28 Hz and 20.76 6 0.54 Hz, respectively) and membrane potential (21.96 6 1.88 mV and 22.83 6 3.59 mV, respectively). However, as shown in Figure 2 , exposing NA(2) neurons to 240 mM and 480 mM isoflurane resulted in a depolarization (+6.36 6 1.20 mV, p < 0.05; +11.56 6 2.24 mV, p < 0.001) and an increase in firing rate (+1.29 6 0.29 Hz, p < 0.001; +2.53 6 0.52 Hz, p < 0.001), nearly tripling or quadrupling their basal firing rates. To determine whether isoflurane was acting pre-or postsynaptically on NA(2) VLPO neurons, we used two independent methods to block synaptic transmission: (1) a combination of the nonselective AMPA and kainate receptor antagonist 6,7-dinitroquinoxaline-2,3-dione (DNQX, 20 mM), the NMDA receptor antagonist (2R)-amino-5-phosphonopentanoate (AP5, 100 mM), and the GABA A receptor antagonist bicuculline (Bic, 20 mM); and (2) aCSF enriched in Mg 2+ (9.68 mM) and depleted in Ca 2+ (160 mM) to block synaptic vesicular release. Both methods were effective at completely abolishing all postsynaptic events ( Figure 3A ), but the isoflurane-induced depolarization and activation of NA(2) VLPO neurons persisted ( Figures 3B and 3C ). In the presence of DNQX+AP5+Bic, 240 mM isoflurane (n = 7) produced an increase in firing rate (+1.30 6 0.85 Hz, p < 0.05) and depolarized the resting membrane potential (+6.23 6 1.63 mV, p < 0.05). In the presence of high Mg 2+ and low Ca 2+ , 240 mM isoflurane (n = 3) produced an increase in firing rate (+1.19 6 0.30 Hz, p < 0.05), but the depolarization of the membrane potential was not significant (+6.47 6 2.83 mV, p > 0.05); 480 mM isoflurane (n = 3) produced an increase in firing rate (+2.36 6 0.54 Hz, p < 0.01) and significantly depolarized the membrane potential (+12.64 6 6.15 mV, p < 0.01).
Isoflurane (240 mM) had no effect on the frequency or amplitude of excitatory or inhibitory postsynaptic currents (EPSCs and IPSCs) and only altered the kinetics of IPSCs, with a prolonged half-width (p < 0.05; Figure 4B ; see also Table S1 available online). In contrast, 240 mM isoflurane produced a pronounced inward current of 12.57 6 2.01 pA when NA(2) neurons were held at 260 mV (p < 0.001). This shift was preserved when 240 mM isoflurane was introduced in the presence of the synaptic inhibitors 20 mM DNQX, 100 mM AP5, and 20 mM Bic, resulting in an inward current of 13.68 6 3.17 pA (p < 0.001) compared to 4.62 6 3.66 pA (p > 0.05, not significant) in the presence of the inhibitors alone ( Figures 4A and 4C) .
The isoflurane-induced depolarization observed in NA(2) neurons was accompanied by an increase in membrane resistance (+377.5 6 106.4 MU, p < 0.05) in 4 out of 4 neurons examined ( Figures 5A and 5B). To determine whether the increased resistance and depolarizing inward current were due to a decreased conductance of chloride or potassium, the chloride reversal potential was shifted from 275 mV to 215 mV, but this had no effect on the magnitude of the inward current (data not shown). However, when NA(2) neurons were held at the reversal potential for potassium (2) neurons and analyzed by two-way ANOVAs with post hoc t tests using the Bonferroni correction for multiple comparisons. Error bars represent SEM. *p < 0.05; **p < 0.01; ***p < 0.001; all comparisons were made against baseline. (E K = 2100 mV), the inward current was drastically reduced (0.65 6 0.52 pA, p < 0.01) and did not differ from 0 pA (p > 0.05; Figure 5C ).
Lesions of VLPO Neurons Produce Initial Resistance to Isoflurane-Induced Hypnosis
A targeted galanin-saporin was used to lesion VLPO bilaterally (n = 15), with an unconjugated saporin used for sham lesions (n = 7) ( Figures 6A-6D ). The lesioned group had an average neuronal loss of 91% 6 2% in VLPO, including the expected specific loss of galanin neurons ( Figure S1 ). At 6 days and 24 days following surgery, all mice were assessed in parallel for their sensitivity to isoflurane using a loss of righting reflex (LORR) paradigm. As depicted in Figure 6E , lesioned mice at 6 days required higher doses of isoflurane to lose their righting reflex than their sham cohorts did; the effect of the lesion was a right shift in the LORR dose-response curve, with a shift of the mean effective dose (ED 50 ) from 0. 
Discussion
The putative sleep-active VLPO neurons project extensively throughout the central nervous system and play a critical role in arousal regulation. Although most neurons within the brain are inactivated upon induction of general anesthesia, herein we demonstrate that the volatile anesthetics can directly activate putative sleep-promoting VLPO neurons. VLPO activation occurs in a dose-dependent fashion at concentrations that precede the onset of anesthetic hypnosis but does not occur at a low, subsedative dose. Using ex vivo electrophysiology, we further show that isoflurane only activates VLPO neurons that are hyperpolarized by NA and exhibit LTS, both of which are hallmarks of cells whose enhanced firing is believed to cause the onset and maintenance of natural sleep. Consistent with this, our c-Fos studies show no difference in VLPO c-Fos expression between mice sacrificed during a period of maximal sleep and anesthetized mice, and no additivity when anesthesia is delivered during the rest phase. To strengthen the correlation between anestheticinduced activation of VLPO and the onset of behavioral hypnosis, we further establish that lesioning of the VLPO is associated with an acute resistance to anesthetic hypnosis. Conversely, when the anesthetic state is antagonized despite ongoing exposure to an anesthetic, c-Fos immunoreactivity in VLPO reverts to awake-like levels, suggesting that the VLPO may be capable of integrating arousal state inputs and need not be influenced exclusively by the anesthetic.
VLPO Activation Is a Common Point of Neuronal Convergence for Many Anesthetics as Well as Sleep
Studies using c-Fos protein immunoreactivity as a marker of antecedent neuronal activity have demonstrated that propofol [7] , barbiturates [7] , dexmedetomidine [10] , and chloral hydrate [11] , among others, increase the number of c-Fospositive neurons in the VLPO, but whether this translates into increased neuronal activation has not been shown. In the current study, we demonstrate that the volatile anesthetic isoflurane not only increases the expression of c-Fos in VLPO neurons but also enhances neuronal excitation. Lu et al.
[11] show that both excitatory (downward deflections) and inhibitory (upward deflections) postsynaptic currents were eliminated by the administration of 20 mM DNQX, 100 mM AP5, and 20 mM bicuculline (Bic) (n = 7), or by the replacement of normal artificial cerebrospinal fluid (aCSF) with a mixture in which Ca 2+ content was reduced to 160 mM and Mg 2+ content increased to 9.68 mM (n = 3). (B and C) Isoflurane, at both 240 mM and 480 mM, was effective at increasing the firing rate (B) and depolarizing the resting membrane potential (C) in NA(2) neurons, both in normal aCSF and in preparations in which all postsynaptic activity was abolished. Data were analyzed using two-way ANOVAs with post hoc t tests using the Bonferroni correction for multiple comparisons. Error bars represent SEM. n.d., not determined; *p < 0.05; **p < 0.01; ***p < 0.001; all comparisons were made against baseline. previously demonstrated that isoflurane exposure increases c-Fos expression in the VLPO, though the anesthetic dose was not measured. Here, we show that clinically relevant hypnotic and sedative doses of isoflurane and halothane are effective at increasing c-Fos in the VLPO, whereas a subsedative dose is not. However, a major drawback to using c-Fos as an indicator of neuronal activity in VLPO is that the VLPO is not a homogenous nucleus. The VLPO consists of two very distinct subpopulations of neurons: two-thirds of the neurons are characterized as being primarily multipolar, having an LTS produced by T-type calcium channels and being inhibited by the wake-promoting neurotransmitter NA, and these are the cells that are believed to be sleep promoting; the remaining one-third are typically bipolar, do not show LTS, are excited by NA, and are state indifferent [15, 24, 25] . Aside from electrophysiological differences, there are currently no known markers available to distinguish between these two subpopulations. Therefore, we used ex vivo whole-cell electrophysiology to establish that the NA(2), but not NA(+), VLPO neurons show increased excitability during exposure to isoflurane.
Isoflurane had no observable effect on NA(+) neurons: there was no significant effect on either membrane potential or firing rate at either isoflurane concentration, demonstrating divergent electrophysiological responses for adjacent NA(+) and NA(2) neurons. Though there was a trend toward a reduction in firing rate in NA(+) neurons, a floor effect may have prevented us from observing the full effects of the drug: both cell types had an average basal firing rate of approximately 1 Hz. Conversely, the putative sleep-active NA(2) neurons were profoundly affected by isoflurane: both doses were effective at depolarizing the neurons and increasing the firing rate. One possible mechanism by which isoflurane could excite NA(2) VLPO neurons is by acting presynaptically to increase glutamate release onto VLPO neurons. In single-cell dissociated neuronal preparations, propofol has been reported to increase glutamate release from presynaptic terminals by acting on presynaptic GABA A receptors, which results in a depolarization due to a shifted chloride gradient [25] . We found that isoflurane, however, had no effect on glutamatergic EPSC frequency (Table S1 ), ruling out this potential mechanism. Isoflurane did increase the half-width of GABA Amediated IPSCs, as has been observed in other neuronal populations [27] . However, isoflurane's potentiation of inhibitory GABAergic signaling should oppose rather than explain isoflurane's depolarizing effect on NA (2) neurons.
Blocking all synaptic input onto VLPO neurons had little impact on isoflurane's effect on NA(2) VLPO neurons' membrane potential and firing rate. In the presence of antagonists blocking all presynaptic activity, or in the presence of high Mg 2+ and low Ca 2+ to prevent synaptic vesicular release, isoflurane still depolarized the NA(2) neurons and produced an increase in firing rate. Consistent with this, in the absence of any synaptic blockers, the only significant effect of isoflurane in voltage-clamp mode (in addition to the aforementioned increase in GABA IPSC half-width) was an increase in inward current. These findings demonstrate that isoflurane must have a direct extrasynaptic effect on NA(2) VLPO neurons. Although surprising, there is existing evidence for such an effect: isoflurane, like most volatile anesthetics, is a promiscuous drug known to affect a wide range of targets [28] . Of isoflurane's known receptor targets, the majority are modulated in a way that would be predicted to lead to an inhibitory effect, but isoflurane can depolarize cells by potentiating cation channels [29, 30] or by closing anion channels such as the tandem pore potassium channels K 2P 12.1 and K 2P 13.1 [31] (reviewed in [2, 17, 32] ). The latter is a congruent mechanism to explain our isoflurane-induced increase in membrane resistance, which is accompanied by an inward current that is abolished at the reversal potential for potassium. Additionally, it should be noted that we cannot exclude a voltage-gated potassium channel from underlying our effect, because the cumulative effects of low open probability could be overcome by abundant channel expression. Hence, although the exact molecular mechanism through which isoflurane depolarizes NA(2) VLPO neurons remains presently unknown, isoflurane's mechanism is clearly distinct from the disinhibition of VLPO that is thought to underlie dexmedetomidine's hypnotic actions [10] .
VLPO Activation Modulates, but Is Not Required for, Anesthetic Hypnosis
Both natural sleep and anesthetic-induced hypnosis produce similarly increased numbers of active neurons in VLPO, but (2) neuron (100 traces averaged). Isoflurane (240 mM) increased IPSC half-width but had no effect on frequency or amplitude for either IPSCs or EPSCs (see Table S1 ). (C) Administration of 240 mM isoflurane increased inward current in NA(2) cells held at a fixed voltage (260 mV), an effect that persisted during synaptic blockade with 20 mM DNQX, 100 mM AP5, and 20 mM bicuculline (n = 7). Data were analyzed using two-way ANOVAs with post hoc t tests using the Bonferroni correction for multiple comparisons. Error bars represent SEM. ***p < 0.001; all comparisons were made against baseline.
there is no additive effect when naturally sleeping mice are anesthetized with isoflurane. Furthermore, by using pressure reversal to decouple anesthetic exposure from its behavioral endpoint of hypnosis, our results demonstrate that VLPO activity correlates with the state of behavioral arousal rather than with the presence or absence of the anesthetic. There are no specific antagonists of general anesthesia; however, other acute interventions including microinjections targeting the centromedial thalamus as well as systemic administration of physostigmine, doxapram, and methylphenidate all have partial efficacy [33] [34] [35] . Pressure reversal has been shown to be effective at a wide range of concentrations for many anesthetics [23] . Though isoflurane is capable of directly activating (2) neuron showing membrane voltage response to bath administration of 240 mM isoflurane; membrane resistance was monitored by measuring the magnitude of the downward voltage deflections in response to 230 pA injected current pulses. Exposure to 240 mM isoflurane depolarized the NA(2) neuron and increased membrane resistance. This increase in resistance was maintained when negative current was applied to return the cell to its baseline resting potential in the presence of isoflurane (data not shown). (B) Isoflurane significantly increased membrane resistance in all four NA(2) neurons. The squares are the individual values for the four neurons in the graph; the horizontal lines represent the mean value in each group. *p < 0.05. (C) Using voltage-clamp techniques, the inward current observed during isoflurane exposure was diminished when the neurons were held at E K (2100 mV). The current produced by isoflurane at 2100 mV was not significantly different from that at 0 pA. Error bars represent SEM. **p < 0.01. Figure S1 ). Lesion efficacy was assessed via cell counts of NeuN-positive cells; the white boxes in (B) and (D) are 250 mm tall by 400 mm wide and correspond to the location used for counting. Two animals out of 17 in the lesion cohort that had less than 80% cell loss in the VLPO compared to shams were excluded from analysis (n = 7 in the sham group). Average neuronal loss in VLPO for lesioned animals was 91% 6 2%. (E) Dose-response curves showing the fraction of unconscious animals as judged by a loss of righting reflex in response to stepwise increases in isoflurane concentrations at 6 and 24 days postsurgery; the horizontal axis is displayed on a logarithmic scale. VLPO lesions produced a significant rightward shift of the induction dose-response curve at day 6 and a significant leftward shift at day 24 (Table S2) . Inset: bracketed ED 50 values as calculated by averaging the last concentration at which an animal had an intact righting reflex with the first concentration at which an animal lost its righting reflex. Error bars represent SEM. *p < 0.05; ***p < 0.001.
sleep-promoting VLPO neurons, when animals exposed to hypnotic levels of isoflurane were behaviorally aroused via pressure reversal, c-Fos counts in VLPO were no different from those in awake controls, suggesting that the VLPO is integrating multiple arousal-related inputs.
The VLPO plays a critical role in promoting sleep [9] , and the data presented here argue for a similar role in anestheticinduced hypnosis. Yet, it is clear that activation of sleeppromoting VLPO neurons is not a requirement for sleepe.g., eszopiclone-induced sleep does not increase VLPO c-Fos [36] -or for the onset of anesthetic-induced hypnosis, as has been demonstrated for ketamine [11] . However, the sleep-active neurons of the VLPO form one site of convergence entwining the neurobiology of endogenous arousal state regulation with anesthetic-induced hypnosis. Consequently, the VLPO is a natural candidate for translating the physiological effects of preexisting sleep deprivation upon resulting anesthetic hypersensitivity [37, 38] .
We used a targeted saporin to lesion galaninergic neurons within VLPO and an unconjugated saporin as a sham control. Previous studies lesioned VLPO with ibotenic acid or orexinsaporin [12, 13] and may have destroyed a different subset of neurons. However, with a similar loss of >90% of all VLPO neurons, galanin-saporin treatment produced a short-term resistance to induction by isoflurane 6 days following the lesion, resulting in a right shift of the LORR dose-response curve, shifting the ED 50 from 0.85% to 0.95% (Table S2) . This is consistent with a published report showing that VLPO lesions produce a foreshortened duration of action of dexmedetomidine [10] , but it is in contrast to a report showing increased burst-suppression ratios-an electroencephalography-dependent measure of anesthetic depth-during exposure to hypnotic levels of isoflurane due to an accumulation of lesion-produced sleep loss [13] . Because sleep loss is a known confound of anesthetic sensitivity [37, 38] , our goal was to examine the effects of the lesion before any significant amount of sleep loss could accrue. Excitotoxic lesions of the VLPO produce pronounced sleep/wake architecture changes by 7 days postlesion [12] , but targeted saporin lesions have a lag time of 4 days before significant cell loss is observed [39] . Therefore, we chose 6 days following saporin lesion to maximize cell loss while minimizing sleep debt accrual. When we reexamined the mice 18 days later, the lesion group was more sensitive to induction by isoflurane, with an ED 50 of 0.78% compared to 0.85% for the sham group (Table S2) . Although we did not use polysomnography to measure sleep and wakefulness in our lesioned mice, we view our findings as consistent with those of Eikermann et al. [13] : VLPO lesions produce an acute resistance to isoflurane anesthesia that over time is reversed to a sensitization due to sleep debt accumulation [12] . Importantly, despite our best attempts, it is possible that an accruing sleep debt 6 days following targeted nanoinjection of galanin-saporin may have minimized a potentially largermagnitude shift in anesthetic resistance that could have resulted from a true acute pharmacologic or genetic inactivation of VLPO. Furthermore, the non-sleep-active NA(+) neurons are also galaninergic [40] and were thus also susceptible to the galanin-saprorin lesion; we would predict that lesioning solely the NA(2) VLPO neurons would produce a larger effect. Based upon preserved temperature and body weight regulation in our lesioned mice, our smallvolume nanoinjections did not spread to the nearby adjacent median preoptic area, which participates in thermoregulation [41] , or the ventromedial hypothalamus, which contributes to maintenance of body weight [42] .
The relatively small magnitude of the effects of a VLPO lesion on the ED 50 of the LORR curve (12% of sham at 6 days), and the fact that this shift can be reversed if the animal's sleep architecture is allowed to be disrupted, suggests that though it may play an important role, the VLPO is neither the sole nor the master mediator of anestheticinduced hypnosis. But this is not unique to anesthesia: VLPO-lesioned rats still sleep [12] . Other sleep-promoting neurons have been discovered in the median preoptic nucleus [43] , basal forebrain [44] , and cortex [45] . Hence, it is likely that despite a VLPO lesion, other sleep-promoting groups remain intact, as would any hypnotic component arising through the modulation of activity in these or other state-dependent neurons.
Conclusion
Although anesthetics are known to increase transcription of the immediate early gene c-fos in VLPO neurons, it has not been previously established whether the activation is a consequence of the inhibition of wake-active sites or is independently due to actions of the anesthetic agents on VLPO neurons. Here we have shown that for isoflurane, this activation is a direct postsynaptic effect resulting from the closure of a background potassium conductance and is specifically limited to the presumed sleep-active NA(2) subpopulation of VLPO neurons. Furthermore, the number of active neurons in the VLPO, as measured by c-Fos, corresponds to the behavioral state of the animal: mice that are naturally sleeping or are exposed to hypnotic or sedative levels of a volatile anesthetic show relatively high numbers of c-Fos-positive neurons in the VLPO, whereas mice that are naturally awake or behaviorally reversed in the presence of an anesthetic show relatively fewer active neurons in VLPO. Although there is still much debate as to how general anesthetics mediate hypnosis, the data presented here are consistent with volatile anesthetics acting via the endogenous sleep circuitry. The specificity with which isoflurane targets solely the sleep-active subpopulation of neurons in VLPO and the tight coupling of VLPO activity with behavioral state are suggestive of a causative, functionally significant relationship between the activation of VLPO by volatile anesthetics and the onset of hypnosis.
Experimental Procedures
All studies were carried out in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and approved by the Institutional Animal Care and Use Committee at the University of Pennsylvania. Previously described protocols were used for righting-reflex assessment of anesthetic sensitivity [18, 19, 46] and slice electrophysiology [47] . Full descriptions of these and other materials and methods are available in the Supplemental Experimental Procedures.
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